
Amer Zeidan/yalemedicine.org
Jul 30, 2025, 08:56
Amer Zeidan: Dynamic Shifts in the MDS Treatment Paradigm
Amer Zeidan, Chief of the Division of Hematologic Malignancies and Professor of Medicine at Yale University, shared a post on X:
“Community Practice Connections: Exploring the Dynamic Shifts in the MDS Treatment Paradigm: Unveiling Advances in Disease Modifying Therapies, Spotlight on Cutting-Edge Clinical Trials, and the Latest Approvals.”
More Posts Featuring MDS.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 30, 2025, 08:56
Jul 30, 2025, 08:52
Jul 30, 2025, 06:38
Jul 30, 2025, 06:30
Jul 29, 2025, 20:21
Jul 29, 2025, 20:19